Literature DB >> 17067553

Resistin increases lipid accumulation and CD36 expression in human macrophages.

Weibin Xu1, Lu Yu, Wenzhong Zhou, Min Luo.   

Abstract

Excessive lipid accumulation in macrophages plays an important role in the development of atherosclerosis. Recently, several studies have implied that resistin, an adipocytokine which is mainly expressed in human peripheral blood monocytes, may take part in the pathogenesis of atherosclerosis. In this study, we investigated the effects of resistin on lipid accumulation as well as oxLDL on resistin expression in human macrophages. Treatment of macrophages with oxLDL significantly increased resistin mRNA expression, whereas native LDL had no such effect. Resistin pre-treated macrophages contained more and larger lipid droplets stained by Nile red. Resistin increased the expression of CD36 at both mRNA and protein levels, without affecting those of class A macrophage scavenger receptor (SR-A). These results suggest that resistin promotes lipid accumulation in human macrophages through its upregulating CD36 cell surface expression. Also, it is suggested that resistin may act as a modulator for macrophage-to-foam cell transformation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17067553     DOI: 10.1016/j.bbrc.2006.10.051

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  Lymphocytes and macrophages in adipose tissue in obesity: markers or makers of subclinical inflammation?

Authors:  Anna Cinkajzlová; Miloš Mráz; Martin Haluzík
Journal:  Protoplasma       Date:  2017-02-01       Impact factor: 3.356

Review 2.  Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations.

Authors:  Kerstin Wolk; Robert Sabat
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

Review 3.  Resistin: functional roles and therapeutic considerations for cardiovascular disease.

Authors:  Md S Jamaluddin; Sarah M Weakley; Qizhi Yao; Changyi Chen
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 4.  Lipid bodies in inflammatory cells: structure, function, and current imaging techniques.

Authors:  Rossana C N Melo; Heloisa D'Avila; Hsiao-Ching Wan; Patrícia T Bozza; Ann M Dvorak; Peter F Weller
Journal:  J Histochem Cytochem       Date:  2011-03-23       Impact factor: 2.479

5.  Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice.

Authors:  Neel S Singhal; Rajesh T Patel; Yong Qi; Yun-Sik Lee; Rexford S Ahima
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-27       Impact factor: 4.310

Review 6.  Leukocyte lipid bodies - Biogenesis and functions in inflammation.

Authors:  Patricia T Bozza; Kelly G Magalhães; Peter F Weller
Journal:  Biochim Biophys Acta       Date:  2009-01-21

7.  Sirt1 inhibits resistin expression in aortic stenosis.

Authors:  Sophie Carter; Stéphanie Miard; Catherine Roy-Bellavance; Louise Boivin; Zhuo Li; Philippe Pibarot; Patrick Mathieu; Frédéric Picard
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

8.  Resistin in rodents and humans.

Authors:  Hyeong Kyu Park; Rexford S Ahima
Journal:  Diabetes Metab J       Date:  2013-12       Impact factor: 5.376

9.  Effect of six-week aerobic exercise on Chemerin and Resistin concentration in hypertensive postmenopausal women.

Authors:  Atieh Aghapour; Parvin Farzanegi
Journal:  Electron Physician       Date:  2013-02-01

Review 10.  Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis.

Authors:  Emily Punch; Justus Klein; Patrick Diaba-Nuhoho; Henning Morawietz; Mahdi Garelnabi
Journal:  J Am Heart Assoc       Date:  2022-01-20       Impact factor: 6.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.